ANACORAntenne d'Accueil et d'Orientation des urgences
References in periodicals archive ?
Berns, Anacors Chairman and Chief Executive Officer, added, "Today marks the beginning of an exciting new chapter for Anacor, which we believe will deliver significant value to our shareholders.
2 billion, which assumes the conversion of Anacors outstanding convertible notes.
In both of its Phase 3 pivotal studies, crisaborole achieved statistically significant results on all primary and secondary endpoints and in March 2016, the FDA accepted for review Anacors New Drug Application seeking approval of crisaborole for the potential treatment of mild-to-moderate atopic dermatitis in children and adults.